BREAST TUMOR
Clinical trials for BREAST TUMOR explained in plain language.
Never miss a new study
Get alerted when new BREAST TUMOR trials appear
Sign up with your email to follow new studies for BREAST TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer drug niraparib studied in PALB2-Mutated tumors
Disease control TerminatedThis study looked at whether the drug niraparib could help people with advanced solid tumors (like breast, lung, or pancreatic cancer) that have a specific PALB2 gene mutation. The goal was to see if the drug could shrink tumors or slow the cancer from growing. The study was stop…
Matched conditions: BREAST TUMOR
Phase: PHASE2 • Sponsor: Tempus AI • Aim: Disease control
Last updated Jun 12, 2026 12:04 UTC
-
Experimental cancer drug study halted early
Disease control TerminatedThis study tested a new drug called NUV-868, alone or with other drugs (olaparib or enzalutamide), in 82 adults with advanced solid tumors like ovarian, pancreatic, prostate, or breast cancer. The goal was to find safe doses and see if the combination worked better. The study was…
Matched conditions: BREAST TUMOR
Phase: PHASE1 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated Jun 09, 2026 12:07 UTC